- Home
- SNOA vs ONFO Comparison
SNOA vs ONFO Comparison
Compare SNOA & ONFO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNOA
- ONFO
- Stock Information
- Founded
- SNOA 1999
- ONFO 2018
- Country
- SNOA United States
- ONFO United States
- Employees
- SNOA N/A
- ONFO N/A
- Industry
- SNOA Biotechnology: Pharmaceutical Preparations
- ONFO Computer Software: Programming Data Processing
- Sector
- SNOA Health Care
- ONFO Technology
- Exchange
- SNOA Nasdaq
- ONFO Nasdaq
- Market Cap
- SNOA 6.4M
- ONFO 5.4M
- IPO Year
- SNOA 2007
- ONFO 2022
- Fundamental
- Price
- SNOA $3.06
- ONFO $1.07
- Analyst Decision
- SNOA
- ONFO
- Analyst Count
- SNOA 0
- ONFO 0
- Target Price
- SNOA N/A
- ONFO N/A
- AVG Volume (30 Days)
- SNOA 52.3K
- ONFO 75.5K
- Earning Date
- SNOA 08-07-2025
- ONFO 08-22-2025
- Dividend Yield
- SNOA N/A
- ONFO N/A
- EPS Growth
- SNOA N/A
- ONFO N/A
- EPS
- SNOA N/A
- ONFO N/A
- Revenue
- SNOA $14,912,000.00
- ONFO $9,087,118.00
- Revenue This Year
- SNOA $23.00
- ONFO N/A
- Revenue Next Year
- SNOA $24.59
- ONFO N/A
- P/E Ratio
- SNOA N/A
- ONFO N/A
- Revenue Growth
- SNOA 17.43
- ONFO 65.97
- 52 Week Low
- SNOA $1.75
- ONFO $0.61
- 52 Week High
- SNOA $5.93
- ONFO $1.88
- Technical
- Relative Strength Index (RSI)
- SNOA 41.95
- ONFO 44.79
- Support Level
- SNOA $2.91
- ONFO $0.94
- Resistance Level
- SNOA $3.16
- ONFO $1.16
- Average True Range (ATR)
- SNOA 0.20
- ONFO 0.10
- MACD
- SNOA -0.03
- ONFO -0.03
- Stochastic Oscillator
- SNOA 24.43
- ONFO 18.86
About SNOA Sonoma Pharmaceuticals Inc.
Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing, and commercializing differentiated therapies for patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes, and others. The company derives revenue from the sale of products in the United States, Latin America, Europe, Asia, and other countries.
About ONFO Onfolio Holdings Inc.
Onfolio Holdings Inc actively manages small online businesses that operate in sectors with long-term growth opportunities, have positive and stable cash flows, face minimal threats of technological or competitive obsolescence, and can be managed by existing teams or have management teams largely in place. The company operates in two business segments: Business to Business (B2B) and Business to Consumers (B2C). The majority of its revenue is generated from the Business-to-Business (B2B) segment, which includes the results of operations of Eastern Standard, RevenueZen, DDS Rank, SEO Butler, Contentellect, DealPipe, and Onfolio LLC.